- Home
- NVG vs LMAT Comparison
NVG vs LMAT Comparison
Compare NVG & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVG
- LMAT
- Stock Information
- Founded
- NVG 1999
- LMAT 1983
- Country
- NVG United States
- LMAT United States
- Employees
- NVG N/A
- LMAT N/A
- Industry
- NVG Investment Managers
- LMAT Medical/Dental Instruments
- Sector
- NVG Finance
- LMAT Health Care
- Exchange
- NVG Nasdaq
- LMAT Nasdaq
- Market Cap
- NVG 2.7B
- LMAT 2.4B
- IPO Year
- NVG N/A
- LMAT 2006
- Fundamental
- Price
- NVG $12.37
- LMAT $91.88
- Analyst Decision
- NVG
- LMAT Buy
- Analyst Count
- NVG 0
- LMAT 7
- Target Price
- NVG N/A
- LMAT $92.83
- AVG Volume (30 Days)
- NVG 568.8K
- LMAT 184.8K
- Earning Date
- NVG 01-01-0001
- LMAT 10-31-2024
- Dividend Yield
- NVG 4.65%
- LMAT 0.71%
- EPS Growth
- NVG N/A
- LMAT 49.21
- EPS
- NVG N/A
- LMAT 1.82
- Revenue
- NVG N/A
- LMAT $213,029,000.00
- Revenue This Year
- NVG N/A
- LMAT $16.04
- Revenue Next Year
- NVG N/A
- LMAT $9.62
- P/E Ratio
- NVG N/A
- LMAT $49.24
- Revenue Growth
- NVG N/A
- LMAT 14.81
- 52 Week Low
- NVG $9.68
- LMAT $52.88
- 52 Week High
- NVG $12.21
- LMAT $109.58
- Technical
- Relative Strength Index (RSI)
- NVG 31.04
- LMAT 32.80
- Support Level
- NVG $12.44
- LMAT $88.77
- Resistance Level
- NVG $13.27
- LMAT $102.66
- Average True Range (ATR)
- NVG 0.16
- LMAT 2.77
- MACD
- NVG -0.09
- LMAT -1.81
- Stochastic Oscillator
- NVG 1.08
- LMAT 13.43
About NVG Nuveen AMT-Free Municipal Credit Income Fund
Nuveen AMT-Free Municipal Credit Income Fund is a diversified, closed-end management investment company. Its objective is to provide current income exempt from regular federal income tax. The Fund invests predominantly in investment grade municipal bonds that are exempt from regular federal income taxes.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.